Impact of Elevated Preprocedural Left Ventricular Filling Pressure on Prognosis of Mild Paravalvular Regurgitation Following Transcatheter Aortic Valve Replacement
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31537 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Shumpei Kosugi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Aortic Valve Insufficiency, Ventricular Function, Left. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
Paravalvular regurgitation (PVR) following transcatheter aortic valve replacement (TAVR) is a complication linked to poor outcomes. The prognostic impact of mild PVR, particularly in patients with elevated preprocedural left ventricular (LV) filling pressure, remains uncertain.
Aims
This study aimed to assess the influence of elevated preprocedural LV filling pressure on mild PVR prognosis following TAVR.
Methods
This single‐center, retrospective study analyzed consecutive patients with severe aortic stenosis who underwent TAVR, excluding those with moderate or severe PVR. Preprocedural LV filling pressure was evaluated using baseline E/A ratio, and patients were stratified into four groups based on E/A ratio (≤1 or >1) and PVR severity (none/trace or mild). The primary endpoint was cardiovascular death within 5 years.
Results
Among 904 patients, 466 had E/A ≤ 1 with none/trace PVR, 92 had E/A > 1 with none/trace PVR, 300 had E/A ≤ 1 with mild PVR, and 46 had E/A > 1 with mild PVR. Multivariable analysis identified E/A > 1 with mild PVR as an independent predictor of cardiovascular death (adjusted hazard ratio [HR]: 2.38; 95% confidence interval [CI]: 1.28–4.42; p < 0.01). In contrast, E/A > 1 with none/trace PVR (HR: 1.16, 95% CI: 0.66–2.03) and E/A ≤ 1 with mild PVR (HR: 1.33, 95% CI: 0.89–2.00) were not significant predictors compared to E/A ≤ 1 with none/trace PVR.
Conclusions
Elevated preprocedural LV filling pressure is independently associated with an increased risk of cardiovascular death in patients with mild PVR following TAVR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
- Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
ORCID-Profile: Shumpei Kosugi, Yutaka Matsuhiro, Shota Okuno, Ai Kawamura, Tomoharu Dohi
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Kosugi, S., Mizote, I., Nakamura, D., Sugae, H., Matsuhiro, Y., Okuno, S., Kawamura, A., Yamashita, K., Maeda, K., Shimamura, K., Dohi, T., Takeda, Y., & Sakata, Y. (2025). Impact of Elevated Preprocedural Left Ventricular Filling Pressure on Prognosis of Mild Paravalvular Regurgitation Following Transcatheter Aortic Valve Replacement. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31537
Vancouver
Kosugi S, Mizote I, Nakamura D, Sugae H, Matsuhiro Y, Okuno S, et al. Impact of Elevated Preprocedural Left Ventricular Filling Pressure on Prognosis of Mild Paravalvular Regurgitation Following Transcatheter Aortic Valve Replacement. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31537
BibTeX
@article{Kosugi2025,
author = {Kosugi, Shumpei and Mizote, Isamu and Nakamura, Daisuke and Sugae, Hiroki and Matsuhiro, Yutaka and Okuno, Shota and Kawamura, Ai and Yamashita, Kizuku and Maeda, Koichi and Shimamura, Kazuo and Dohi, Tomoharu and Takeda, Yasuharu and Sakata, Yasushi},
title = {Impact of Elevated Preprocedural Left Ventricular Filling Pressure on Prognosis of Mild Paravalvular Regurgitation Following Transcatheter Aortic Valve Replacement},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31537}
}
EUVIMED